Medicine & Life Sciences

1. Type 1 Diabetes Mellitus 100%
2. B-Cell Chronic Lymphocytic Leukemia 76%
3. Acute Myeloid Leukemia 58%
4. Survival 53%
5. Autoantibodies 48%
6. Multiple Myeloma 47%
7. Rituximab 42%
8. C-Peptide 38%
9. Progression-Free Survival 36%
10. Non-Hodgkin's Lymphoma 36%
11. Therapeutics 34%
12. Thalidomide 33%
13. Bortezomib 28%
14. Drug Therapy 28%
15. Non-Small Cell Lung Carcinoma 27%
16. midostaurin 25%
17. Decitabine 25%
18. Hematopoietic Stem Cell Transplantation 24%
19. Clinical Trials 24%
20. Neoplasms 23%
21. Dexamethasone 22%
22. Glucose Tolerance Test 21%
23. Biomarkers 21%
24. Immunoglobulin Light-chain Amyloidosis 20%
25. Ionizing Radiation 20%
26. Pentostatin 19%
27. Cyclophosphamide 19%
28. Lymphocyte Count 19%
29. Myelodysplastic Syndromes 19%
30. Mutation 17%
31. Acute Promyelocytic Leukemia 17%
32. Lymphoma 16%
33. B-Lymphocytes 16%
34. Stem Cell Transplantation 16%
35. Transplants 16%
36. Atomic Bomb Survivors 16%
37. Single Nucleotide Polymorphism 16%
38. Area Under Curve 15%
39. Confidence Intervals 15%
40. Leukemia 15%
41. Lenalidomide 15%
42. Lymphocytes 14%
43. Amyloidosis 13%
44. Glucose 13%
45. Genes 13%
46. Lymphoproliferative Disorders 13%
47. T-Lymphocytes 13%
48. tipifarnib 13%
49. Immunoglobulin Light Chains 13%